By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xencor 

111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350


SEARCH JOBS
Xencor, a privately held company, is focused on using its cutting edge protein analysis and optimization technologies to accelerate the discovery of therapeutic proteins and novel compounds. With its proprietary ProCode™ and Protein Design Automation™ (PDA™) technologies, Xencor scientists can rapidly determine the interactions and functions of a cell’s entire protein complement, identify proteins of interest, and then optimize key properties of these proteins to fit commercial applications. The use of these technologies alone, or in combination, will accelerate the compound identification and development programs of Xencor’s strategic partners in the pharmaceutical, biotechnology, and agricultural and chemical industries.

Further information is available at www.xencor.com.

Contacts:

Dr. Bassil I. Dahiyat, President and CEO

Dr. E. William Radany, CBO

Dr. Atusha Patel, Manager, Business Development

Last Updated: 3-25-02


Key Statistics


Email: info@xencor.com
Ownership: Private

Web Site: Xencor
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Drug Discovery





Company News
Xencor Reports Second Quarter 2017 Financial Results 8/8/2017 12:05:36 PM
Xencor To Host Second Quarter 2017 Financial Results Webcast And Conference Call On August 7, 2017 7/31/2017 1:31:07 PM
Xencor Presents Interim Data From An Ongoing, Open-Label, Phase II Study of XmAb5871 In Igg4-Related Disease At EULAR 2017 6/16/2017 6:35:53 AM
Xencor Appoints Raphael Clynes, M.D., Ph.D., As Vice President Of Translational Biology 6/8/2017 7:14:41 AM
Xencor's Lead Drug Candidate, Xmab5871, Receives Orphan Drug Designation From FDA For Treatment Of Igg4-Related Disease 5/11/2017 7:22:37 AM
Xencor Reports First Quarter 2017 Financial Results 5/10/2017 10:49:29 AM
Xencor To Host First Quarter 2017 Financial Results Webcast And Conference Call On May 9, 2017 5/2/2017 10:43:52 AM
Xencor Appoints Kevin Gorman, Ph.D., To Its Board Of Directors 4/17/2017 6:54:49 AM
Xencor Reports Fourth Quarter And Full Year 2016 Financial Results 3/1/2017 9:56:17 AM
Xencor To Host Fourth Quarter And Full Year 2016 Financial Results Webcast And Conference Call On February 28, 2017 2/22/2017 11:10:07 AM
12345678910...
//-->